Xuan Jiang

701 total citations
17 papers, 464 citations indexed

About

Xuan Jiang is a scholar working on Oncology, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Xuan Jiang has authored 17 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Reproductive Medicine. Recurrent topics in Xuan Jiang's work include Ovarian cancer diagnosis and treatment (4 papers), PARP inhibition in cancer therapy (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Xuan Jiang is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), PARP inhibition in cancer therapy (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Xuan Jiang collaborates with scholars based in China, Chile and United States. Xuan Jiang's co-authors include Huimin Bai, Zhenyu Zhang, Weihua Li, Guangyi Gao, Wei Wang, Gang Cao, Lin Chen, Ni Zhang, Chao Gao and Hongzhi Zou and has published in prestigious journals such as Gastroenterology, Frontiers in Immunology and Nutrients.

In The Last Decade

Xuan Jiang

15 papers receiving 460 citations

Peers

Countries citing papers authored by Xuan Jiang

Since Specialization

Citations

This map shows the geographic impact of Xuan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuan Jiang more than expected).

Fields of papers citing papers by Xuan Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuan Jiang. The network helps show where Xuan Jiang may publish in the future.

Co-authorship network of co-authors of Xuan Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuan Jiang. A scholar is included among the top collaborators of Xuan Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuan Jiang. Xuan Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Resistin in cardiac diseases: from molecular mechanisms to clinical implications 2025 ·Frontiers in Endocrinology ·(unknown), Bai‐Xue Han, (unknown), Xuan Jiang	0
2	Genomic characteristics of PD-L1-Induced resistance to EGFR-TKIs in lung adenocarcinoma 2024 ·Future Oncology ·(unknown), (unknown), (unknown), (unknown), Xuan Jiang, Zhenzhou Yang, Xiaoyue Zhang	0
3	Mechanisms of autophagy and their implications in dermatological disorders 2024 ·Frontiers in Immunology ·Shibei Xue, (unknown), (unknown), (unknown), (unknown), Xuan Jiang, Zhongyu Han, Ke Wang	3
4	Endogenous n-3 PUFAs Improve Non-Alcoholic Fatty Liver Disease through FFAR4-Mediated Gut–Liver Crosstalk 2023 ·Nutrients ·Xuan Jiang, Qin Yang, Hongyan Qu, Yong Q. Chen, Shenglong Zhu	11
5	Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS 2022 ·Frontiers in Pharmacology ·(unknown), Lin Chen, (unknown), (unknown), Xuan Jiang, Ni Zhang	48
6	Afatinib Targeted Therapy Affects the Immune Function and Serum Levels of EGFR and Gastrin-Releasing Peptide Precursor (pro-GRP) in Patients with Non-Small-Cell Lung Cancer (NSCLC) 2022 ·Disease Markers ·Wei Cao, Jun Ma, Xuan Jiang, Guangyi Gao	3
7	First-line treatment options for advanced non-small cell lung cancer patients with PD-L1 ≥ 50%: a systematic review and network meta-analysis 2021 ·Cancer Immunology Immunotherapy ·Mingfeng He, (unknown), Xiaoyue Zhang, Yuan Peng, Xuan Jiang, Yu‐Sheng Huang, Benxu Tan, Zhenzhou Yang	10
8	In silico analysis identifies neuropilin-1 as a potential therapeutic target for SARS-Cov-2 infected lung cancer patients 2021 ·Aging ·Song Hu, (unknown), (unknown), Chuwen Lin, Xuan Jiang	6
9	Triptolide decreases tumor‐associated macrophages infiltration and M2 polarization to remodel colon cancer immune microenvironment via inhibiting tumor‐derived CXCL12 2020 ·Journal of Cellular Physiology ·Xuan Jiang, Gang Cao, Guangyi Gao, Wei Wang, (unknown), Chao Gao	50
10	Identification of Somatic Mutations in Papanicolaou Smear DNA and Plasma Circulating Cell-Free DNA for Detection of Endometrial and Epithelial Ovarian Cancers: A Pilot Study 2020 ·Frontiers in Oncology ·Xuan Jiang, Weihua Li, Jiaxin Yang, Shuzhen Wang, Dongyan Cao, Mei Yu, Keng Shen, Jian Bai, Yang Gao	7
11	Potential interaction between lysophosphatidic acid and tumor-associated macrophages in ovarian carcinoma 2020 ·Journal of Inflammation ·Ying Feng, (unknown), Zihan Zhang, Ran Cui, Xuan Jiang, Shuzhen Wang, Huimin Bai, Chongdong Liu, Zhenyu Zhang	23
12	<p>Current status and future prospects of PARP inhibitor clinical trials in ovarian cancer</p> 2019 ·Cancer Management and Research ·Xuan Jiang, Weihua Li, (unknown), Huimin Bai, Zhenyu Zhang	81
13	PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms 2019 ·Journal of Cellular and Molecular Medicine ·Xuan Jiang, (unknown), Weihua Li, Huimin Bai, Zhenyu Zhang	112
14	Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age 2017 ·World Journal of Surgical Oncology ·Xuan Jiang, Jiaxin Yang, Mei Yu, Weimin Xie, Dongyan Cao, Ming Wu, Lingya Pan, Huifang Huang, Yan You, Keng Shen	33
15	High Detection Rates of Colorectal Neoplasia by Stool DNA Testing With a Novel Digital Melt Curve Assay 2008 ·Gastroenterology ·Hongzhi Zou, William R. Taylor, Jonathan J. Harrington, (unknown), Xiaoming Cao, Charles L. Loprinzi, (unknown), Douglas K. Rex, Dennis J. Ahnen, Kandice Knigge, Peter Lance, Xuan Jiang, Jeremy C. Smith, David A. Ahlquist	72
16	T1102 Detection of Colorectal Neoplasia By Stool DNA Testing: High Discrimination with Multi-Marker Quantitation 2008 ·Gastroenterology ·Xuan Jiang, Jonathan J. Harrington, Douglas W. Mahoney, Ann L. Oberg, Mary E. Devens, Julie Simonson, David A. Ahlquist, Hongzhi Zou	4
17	753 Stool DNA Screening of Colorectal Neoplasia: Improved Adenoma Detection By Novel Digital Melt Curve Assay 2008 ·Gastroenterology ·Hongzhi Zou, Jonathan J. Harrington, Xuan Jiang, Charles L. Loprinzi, Theodore R. Levin, Douglas K. Rex, Dennis J. Ahnen, Kandice Knigge, Peter Lance, Daniel J. Sargent, David A. Ahlquist	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact